Advances in Urology

The Treatment of Iatrogenic Male Incontinence: Latest Results and Future Perspectives


Publishing date
01 Jun 2012
Status
Published
Submission deadline
02 Dec 2011

1Division of Urology, Department of Surgery, San Paolo Hospital, 17100 Savona, Italy

2Center for Genitourinary Reconstruction, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA

3Department of Urology, Ludwig-Maximilian University, Marchioninistrasse 15, 81377 Munich, Germany

4Department of Urology, Weinviertel Klinikum Korneuburg, 3-5 Wiener Ring, 2100 Korneuburg, Austria


The Treatment of Iatrogenic Male Incontinence: Latest Results and Future Perspectives

Description

The iatrogenic male incontinence remains a critical determinant in the health-related quality of life after surgery. In the early postoperative period, the physicians usually tend to suggest a conservative management including pelvic floor muscle training and pharmacologic treatments. However, in case of persistence of incontinence, patients are offered invasive alternatives as the injections of bulking agents, the balloon compression device procedure, the suburethral sling positioning, and the artificial urinary sphincter implantation. In spite of many less invasive techniques being proposed in the last years, the artificial urinary sphincter seems to represent, until today, the gold standard treatment by which other surgical management must be still compared.

We invite authors to submit original researches and review articles regarding the pathogenesis of male iatrogenic incontinence, the evaluation of the present outcomes, and the development of future treatment options. We are particularly interested in papers describing new nonsurgical approaches and less invasive procedures, with particular attention to cell-based therapy. The authors are asked to report a critical evaluation of these treatment options showing their results and complications. Potential topics include, but are not limited to:

  • Physiopathology of iatrogenic male incontinence
  • Recent developments in pelvic muscle training, biofeedback, or electrical stimulation
  • New pharmacological therapies
  • The role of bulking agents injection therapy
  • The role of balloon compression device positioning
  • The role of suburethral sling surgery including bone-anchored, readjustable, and transobturator slings systems
  • The role of artificial urinary sphincter implantation
  • Recent advances in stem cell therapy

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/au/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

Advances in Urology
 Journal metrics
Acceptance rate7%
Submission to final decision74 days
Acceptance to publication20 days
CiteScore1.290
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.